Alturas Analytics is pleased to announce the appointment of Maggie McMullen as Chief Business Development Officer.

Maggie’s primary objective as Chief Business Development Officer at Alturas Analytics is to strengthen business planning strategies and focus on building relationships, both internal and external, to foster growth as a leader in the LC-MS/MS and GC-MS/MS bioanalytical fields. She comes to Alturas with 10 years of laboratory bench and study director experience, as well as 18 years in CRO business development. Maggie’s technical expertise provides a foundation to help clients effectively move their project through the drug development process.

“We recruit talented and knowledgeable people with great dispositions,” says Robin Woods, Alturas President. “Maggie’s responsiveness and dedication to clients is a great match to Alturas’ commitment to exceptional customer service. We are confident that Maggie’s diverse history within the pharmaceutical industry and related fields will further contribute to Alturas’ growth and prosperity.”

Welcome, Maggie!